Published in J Psychoactive Drugs on February 27, 2004
Research on the diffusion of evidence-based treatments within substance abuse treatment: a systematic review. J Subst Abuse Treat (2008) 2.42
Empirically supported substance abuse treatment approaches: a survey of treatment providers' perspectives and practices. Addict Behav (2007) 1.25
HIV testing in correctional agencies and community treatment programs: the impact of internal organizational structure. J Subst Abuse Treat (2007) 1.21
Organizational characteristics of drug abuse treatment programs for offenders. J Subst Abuse Treat (2007) 0.98
Rural drug users: factors associated with substance abuse treatment utilization. Int J Offender Ther Comp Criminol (2010) 0.90
Barriers to substance abuse treatment in rural and urban communities: counselor perspectives. Subst Use Misuse (2014) 0.83
Treatment outcomes for prescription drug misusers: the negative effect of geographic discordance. J Subst Abuse Treat (2014) 0.77
Rural substance use treatment centers in the United States: an assessment of treatment quality by location. Am J Drug Alcohol Abuse (2015) 0.77
Assessing Differences in the Availability of Opioid Addiction Therapy Options: Rural Versus Urban and American Indian Reservation Versus Nonreservation. J Rural Health (2016) 0.77
Workforce professionalism in drug treatment services: impact of California's Proposition 36. J Subst Abuse Treat (2010) 0.75
Pilot Outcome Results of Culturally Adapted Evidence-Based Substance Use Disorder Treatment with a Southwest Tribe. Addict Behav Rep (2016) 0.75
Adoption and implementation of new technologies in substance abuse treatment. J Subst Abuse Treat (2002) 3.91
Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network. J Subst Abuse Treat (2007) 2.88
Retaining counseling staff at substance abuse treatment centers: effects of management practices. J Subst Abuse Treat (2003) 2.84
Early adoption of buprenorphine in substance abuse treatment centers: data from the private and public sectors. J Subst Abuse Treat (2006) 2.73
Modeling the use of innovations in private treatment organizations: the role of absorptive capacity. J Subst Abuse Treat (2004) 2.51
Buprenorphine diffusion: the attitudes of substance abuse treatment counselors. J Subst Abuse Treat (2005) 2.36
The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters. Drug Alcohol Depend (2006) 2.30
Counselor emotional exhaustion and turnover intention in therapeutic communities. J Subst Abuse Treat (2006) 2.13
Trends in the adoption of medications for alcohol dependence. J Clin Psychopharmacol (2006) 2.13
Problem drinking patterns among African Americans: the impacts of reports of discrimination, perceptions of prejudice, and "risky" coping strategies. J Health Soc Behav (2003) 1.97
Service delivery in substance abuse treatment: reexamining "comprehensive" care. J Behav Health Serv Res (2007) 1.93
Research participation and turnover intention: An exploratory analysis of substance abuse counselors. J Subst Abuse Treat (2007) 1.92
Adoption and implementation of medications in addiction treatment programs. J Addict Med (2011) 1.89
Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat (2009) 1.66
Clinical supervision, emotional exhaustion, and turnover intention: a study of substance abuse treatment counselors in the Clinical Trials Network of the National Institute on Drug Abuse. J Subst Abuse Treat (2008) 1.59
Structural and cultural barriers to the adoption of smoking cessation services in addiction treatment organizations. J Addict Dis (2010) 1.55
Impact of vital signs screening & clinician prompting on alcohol and tobacco screening and intervention rates: a pre-post intervention comparison. BMC Fam Pract (2010) 1.53
Opioid treatment programs in the Clinical Trials Network: representativeness and buprenorphine adoption. J Subst Abuse Treat (2008) 1.40
Research network involvement and addiction treatment center staff: counselor attitudes toward buprenorphine. Am J Addict (2007) 1.40
Organizational-level predictors of adoption across time: naltrexone in private substance-use disorders treatment centers. J Stud Alcohol Drugs (2007) 1.39
The use of antidepressant medications in substance abuse treatment: the public-private distinction, organizational compatibility, and the environment. J Health Soc Behav (2007) 1.39
Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. Am J Public Health (2012) 1.35
A categorical typology of naltrexone-adopting private substance abuse treatment centers. J Subst Abuse Treat (2007) 1.34
Counselor attitudes toward the use of motivational incentives in addiction treatment. Am J Addict (2010) 1.33
Differences in prevalence of prescription opiate misuse among rural and urban probationers. Am J Drug Alcohol Abuse (2007) 1.30
The adoption of alcohol pharmacotherapies in the Clinical Trials Network: the influence of research network participation. J Subst Abuse Treat (2010) 1.30
Counselor attitudes toward pharmacotherapies for alcohol dependence. J Stud Alcohol Drugs (2009) 1.30
Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure. Eval Program Plann (2011) 1.25
Applying team-based learning in primary care residency programs to increase patient alcohol screenings and brief interventions. Acad Med (2009) 1.24
Early adoption of injectable naltrexone for alcohol-use disorders: findings in the private-treatment sector. J Stud Alcohol Drugs (2010) 1.22
Predicting closure of private substance abuse treatment facilities. J Behav Health Serv Res (2002) 1.21
Availability of integrated care for co-occurring substance abuse and psychiatric conditions. Community Ment Health J (2006) 1.20
Partner relationships and HIV risk behaviors among women offenders. J Psychoactive Drugs (2008) 1.16
Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. Drug Alcohol Depend (2010) 1.15
Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations. J Addict Med (2010) 1.15
A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation. J Stud Alcohol Drugs (2011) 1.14
Job stress and poor sleep quality: data from an American sample of full-time workers. Soc Sci Med (2007) 1.10
Diffusion of contingency management and attitudes regarding its effectiveness and acceptability. Subst Abus (2010) 1.03
Evidence-based treatment for opiate-dependent clients: availability, variation, and organizational correlates. Am J Drug Alcohol Abuse (2006) 1.01
OxyContin® as currency: OxyContin® use and increased social capital among rural Appalachian drug users. Soc Sci Med (2012) 1.00
Occupational turnover intentions among substance abuse counselors. J Subst Abuse Treat (2010) 1.00
Total quality management and performance in substance abuse treatment centers. Health Serv Res (2010) 1.00
Health, mental health, substance use, and service utilization among rural and urban incarcerated women. Womens Health Issues (2007) 0.99
Physicians in the substance abuse treatment workforce: understanding their employment within publicly funded treatment organizations. J Subst Abuse Treat (2012) 0.98
Risky relationships: targeting HIV prevention for women offenders. AIDS Educ Prev (2012) 0.98
Organizational factors associated with the use of contingency management in publicly funded substance abuse treatment centers. J Subst Abuse Treat (2010) 0.97
Does service diversification enhance organizational survival?: Evidence from the private substance abuse treatment system. J Behav Health Serv Res (2005) 0.96
Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States. J Stud Alcohol Drugs (2013) 0.96
Racial and ethnic disparities in SSRI availability in substance abuse treatment. Psychiatr Serv (2007) 0.96
Why are recovering substance abuse counselors paid less? Subst Abus (2007) 0.95
Characteristics of hospitals with lowest costs in management of pediatric appendicitis. J Pediatr Surg (2013) 0.95
Financial factors and the implementation of medications for treating opioid use disorders. J Addict Med (2012) 0.95
HIV/AIDS services in private substance abuse treatment programs. Drug Alcohol Depend (2010) 0.95
A changed America? The effects of September 11th on depressive symptoms and alcohol consumption. J Health Soc Behav (2005) 0.94
Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages. J Subst Abuse Treat (2011) 0.94
Management systems, patient quality improvement, resource availability, and substance abuse treatment quality. Health Serv Res (2011) 0.94
Counselor training in several evidence-based psychosocial addiction treatments in private US substance abuse treatment centers. Drug Alcohol Depend (2011) 0.94
The availability of psychiatric programs in private substance abuse treatment centers, 1995 to 2001. Psychiatr Serv (2004) 0.93
Examination of an interventionist-led HIV intervention among criminal justice-involved female prisoners. J Exp Criminol (2009) 0.93
Injection risk behaviors among rural drug users: implications for HIV prevention. AIDS Care (2011) 0.92
Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs. J Subst Abuse Treat (2012) 0.91
Drug abuse treatment beyond prison walls. Addict Sci Clin Pract (2009) 0.89
The relationship of stress, impulsivity, and beliefs to drug use severity in a sample of women prison inmates. Int J Offender Ther Comp Criminol (2007) 0.89
Predominantly female caseloads: identifying organizational correlates in private substance abuse treatment centers. J Behav Health Serv Res (2004) 0.88
What are the correlates of substance abuse treatment counselor salaries? J Subst Abuse Treat (2005) 0.88
Racial and Gender Discrimination in the Stress Process: Implications for African American Women's Health and Well-Being. Sociol Perspect (2013) 0.88
Reducing risky relationships: a multisite randomized trial of a prison-based intervention for reducing HIV sexual risk behaviors among women with a history of drug use. AIDS Care (2014) 0.87
Skills-based residency training in alcohol screening and brief intervention: results from the Georgia-Texas "Improving Brief Intervention" Project. Subst Abus (2012) 0.87
Modified therapeutic communities and adherence to traditional elements. J Psychoactive Drugs (2009) 0.86
Counselor attitudes toward the use of naltrexone in substance abuse treatment: a multi-level modeling approach. Addict Behav (2011) 0.86
Nurse turnover in substance abuse treatment programs affiliated with the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat (2010) 0.86
Turnover intention and emotional exhaustion "at the top": adapting the job demands-resources model to leaders of addiction treatment organizations. J Occup Health Psychol (2009) 0.85
Racial and Ethnic Composition as a Correlate of Medication Availability within Addiction Treatment Organizations. Sociol Focus (2009) 0.85
Assessment and treatment of co-occurring eating disorders in publicly funded addiction treatment programs. Psychiatr Serv (2008) 0.85
Increasing prevalence of prescription opiate misuse over time among rural probationers. J Opioid Manag (2007) 0.84
Drug use and criminal activity among rural probationers with DUI histories. Int J Offender Ther Comp Criminol (2008) 0.83
The roles of spirituality in the relationship between traumatic life events, mental health, and drug use among African American women from one southern state. Subst Use Misuse (2013) 0.83
Prevalence of HIV and risky sexual behaviors among rural drug users: does age matter? Ann Epidemiol (2012) 0.83
The use of art and music therapy in substance abuse treatment programs. J Addict Nurs (2014) 0.83
Gender-specific factors associated with community substance abuse treatment utilization among incarcerated substance users. Int J Offender Ther Comp Criminol (2008) 0.82
Dissemination activities: a critical new role for substance abuse treatment organizations. J Behav Health Serv Res (2014) 0.82
Reinventing the reel: an innovative approach to resident skill-building in motivational interviewing for brief intervention. Subst Abus (2012) 0.81
Quality of clinical supervision and counselor emotional exhaustion: the potential mediating roles of organizational and occupational commitment. J Subst Abuse Treat (2013) 0.80
Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia. J Med Virol (2012) 0.80
The relationship between Clinical Trial Network protocol involvement and quality of substance use disorder treatment. J Subst Abuse Treat (2013) 0.79
Controlled-release oxycodone admissions in public and private substance abuse treatment: associations with organizational characteristics. J Addict Dis (2007) 0.79
Social workers' knowledge and perceptions of effectiveness and acceptability of medication assisted treatment of substance use disorders. Soc Work Health Care (2013) 0.79